fda semaglutide obesity Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US as the first oral GLP‑1 receptor agonist for long‑term weight management and CV risk Semaglutide for weight loss -

Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis

It has also been associated with psychogeriatric dis-ease, depression, high neurotoxin activity, and a decrease in intellectual function such as episodic and visuospatial memory, attention, and abstract reasoning (4, 20).Reynolds and colleagues found that 17 out of 24 hospitalized patients (71%) presenting severe folic acid deficiency were diagnosed with depression (46)

Repositioning glucagon action in the physiology and pharmacology of diabetes

Blood lactate levels were determined at rest as well as four and fourteen minutes post exercise

SELECT trial (2023)